| CERC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CERC shares outstanding history going back to 11/13/2015:
Also see: CERC Market Cap History CERC YTD Return |
As of 7/30/2021 Cerecor has 96.01 million CERC shares outstanding. Investors often track the CERC shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CERC share count trends over time, with 26 historical shares outstanding datapoints presented, dating back to 11/13/2015.

| CERC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CERC shares outstanding history going back to 11/13/2015:
Also see: CERC Market Cap History CERC YTD Return |
| CERC Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
CERC Historical Shares Outstanding: +51.76% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CERC Stock Price Chart |
| About Avalo Therapeutics Inc |
| Cerecor is a biopharmaceutical company. Co.'s pediatric rare disease pipeline is led by CERC-801, CERC-802 and CERC-803, which are therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation. Co. is also developing CERC-002, CERC-006 and CERC-007. CERC-007 is an anti-IL-18 monoclonal antibody being developed for the treatment of autoimmune inflammatory diseases such as Adult Onset Stills Disease and Multiple Myeloma. CERC-006 is a dual mTOR inhibitor being developed for the treatment of complex Lymphatic Malformations. CERC-002 is an anti-LIGHT monoclonal antibody being developed for the treatment of Pediatric-onset Crohn's Disease. We show 26 historical shares outstanding datapoints in our coverage of CERC's shares outstanding history. Understanding the changing numbers of CERC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CERC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CERC by allowing them to research CERC shares outstanding history as well as any other stock in our coverage universe. |
| CERC Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| CERC Share Performance |
| Shares Outstanding Peers |
| Cerecor (CERC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CERE Shares Outstanding History CERS Shares Outstanding History CFMS Shares Outstanding History CFRX Shares Outstanding History CGEM Shares Outstanding History CGEN Shares Outstanding History CGIX Shares Outstanding History CGNT Shares Outstanding History CGON Shares Outstanding History CGTX Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.